{"product_id":"saliva-testing-a-painless-alternative-for-monitoring-medications-and-precision-dosing","title":"Saliva Testing: A Painless Alternative for Monitoring Medications and Precision Dosing","description":"\u003cp\u003eTherapeutic drug monitoring (TDM) traditionally requires blood draws, which can be painful and difficult for vulnerable patients. This review of 112 scientific articles examined whether saliva could serve as an alternative testing fluid, finding that 53 of 73 drugs studied (73.6%) can be reliably monitored through saliva. Researchers also developed mathematical models that use saliva drug levels to guide precise medication dosing, with promising results for antibiotics, antifungal drugs, seizure medications, and steroids. This patient-friendly article explains which drugs work with saliva testing, how the research was conducted, and what these findings could mean for the future of medication management.\u003c\/p\u003e\n\n\u003ch1\u003eSaliva Testing: A Painless Alternative for Monitoring Medications and Precision Dosing\u003c\/h1\u003e\n\n\u003ch2\u003eTable of Contents\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#ddn-key-points\"\u003eKey Points\u003c\/a\u003e\u003c\/li\u003e\n\n  \u003cli\u003e\u003ca href=\"#background\"\u003eWhy This Research Matters\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#methods\"\u003eHow the Researchers Conducted This Review\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#findings\"\u003eKey Findings: Which Drugs Can Be Monitored Through Saliva?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#drugs\"\u003eRepresentative Research Cases\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#factors\"\u003eFactors That Affect Saliva Drug Levels\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#implications\"\u003eWhat This Means for Patients\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#limitations\"\u003eStudy Limitations\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#recommendations\"\u003eRecommendations for Patients and Researchers\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#ddn-faq\"\u003eFrequently Asked Questions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#source\"\u003eSource Information\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c!-- ddn:keypoints:start --\u003e\n\u003ch2 id=\"ddn-key-points\"\u003eKey Points\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eOf 73 drugs studied, 53 (73.6%) could be reliably monitored through saliva, while 13 were unsuitable and 7 had conflicting evidence.\u003c\/li\u003e\n\u003cli\u003eSaliva reflects free, active drug levels; mathematical models can guide precise dosing from saliva samples for antibiotics, antifungals, seizure drugs, and steroids.\u003c\/li\u003e\n\u003cli\u003eIn newborns, saliva-based monitoring for amikacin and gentamicin achieved target levels in 77.6–81% of simulated patients, reducing the need for blood draws.\u003c\/li\u003e\n\u003cli\u003eSaliva collection is painless, requires no training, and can be done at home, but accuracy depends on saliva flow, timing, hydration, and mouth rinsing after liquid medications.\u003c\/li\u003e\n\u003cli\u003eDrugs with high protein binding and low permeability, called SECS Class IV, generally cannot be measured in saliva; laboratory tests must be sensitive enough for low levels.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- ddn:keypoints:end --\u003e\n\n\n\u003ch2 id=\"background\"\u003eWhy This Research Matters\u003c\/h2\u003e\n\u003cp\u003eWhen you take a medication, the level of that drug in your body determines whether it will work effectively or cause harmful side effects. \u003cstrong\u003eTherapeutic drug monitoring (TDM)\u003c\/strong\u003e is the practice of measuring drug concentrations in blood or other body fluids to make sure levels stay within a \"therapeutic window\" — high enough to be effective, but low enough to avoid toxicity.\u003c\/p\u003e\n\u003cp\u003eThink of it like tuning a guitar: too loose and it won't play correctly; too tight and the string snaps. Similarly, if a medication level is too low, it won't treat the condition; if too high, it can cause dangerous side effects.\u003c\/p\u003e\n\u003cp\u003eTraditionally, TDM relies on blood samples, which must be collected by trained professionals using needles. This approach has several drawbacks:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePain and anxiety\u003c\/strong\u003e — especially for children and needle-phobic patients\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRisk of infection\u003c\/strong\u003e — any needle stick carries some risk\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePotential for iatrogenic anemia\u003c\/strong\u003e — blood loss from repeated sampling, particularly dangerous for premature babies\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRequires trained personnel\u003c\/strong\u003e — limiting its use in home or remote settings\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSaliva offers an intriguing alternative. Because of their large molecular size, protein-bound drugs rarely enter saliva, which means salivary drug concentrations actually reflect the \u003cstrong\u003efree (unbound) drug\u003c\/strong\u003e — the portion that is biologically active in the body. Saliva collection is painless, cost-effective, requires no special training, and can be done almost anywhere.\u003c\/p\u003e\n\u003cp\u003eThe researchers also explored \u003cstrong\u003emodel-informed precision dosing (MIPD)\u003c\/strong\u003e, a sophisticated approach that uses mathematical modeling and computer simulation to combine patient information (like age, weight, and organ function), drug properties, and disease characteristics to determine the exact dose each individual needs.\u003c\/p\u003e\n\n\u003ch2 id=\"methods\"\u003eHow the Researchers Conducted This Review\u003c\/h2\u003e\n\u003cp\u003eThe research team from Fujian Medical University Union Hospital in China conducted a systematic search of the PubMed database, looking for all studies on saliva-based TDM published from the database's beginning through November 2024. They used keywords including \"Therapeutic Drug Monitoring,\" \"Saliva,\" \"Salivary,\" and \"Oral fluid.\"\u003c\/p\u003e\n\u003cp\u003eStudies were included only if they met strict criteria:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003eInvolved human participants\u003c\/li\u003e\n  \u003cli\u003eProvided paired saliva and plasma drug concentration data\u003c\/li\u003e\n  \u003cli\u003eWere published in English\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eStudies were excluded if they involved animals, were review articles, were published in other languages, lacked saliva pharmacokinetic data, had no full text available, or showed no relationship between plasma and saliva concentrations.\u003c\/p\u003e\n\u003cp\u003eAfter screening, \u003cstrong\u003e112 articles were included in the final review\u003c\/strong\u003e, published between \u003cstrong\u003e1979 and 2023\u003c\/strong\u003e. These studies covered \u003cstrong\u003e73 different drugs\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003ch2 id=\"findings\"\u003eKey Findings: Which Drugs Can Be Monitored Through Saliva?\u003c\/h2\u003e\n\u003cp\u003eThe results were encouraging but not universal. Not every drug appears in saliva at measurable levels.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e53 drugs (73.6%)\u003c\/strong\u003e — studies supported saliva as a reliable matrix for TDM\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e13 drugs (17.8%)\u003c\/strong\u003e — studies did not support saliva-based TDM\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e7 drugs (9.6%)\u003c\/strong\u003e — studies produced conflicting results, with some supporting and some rejecting saliva testing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWhether a drug can be monitored in saliva depends on several key properties. The researchers describe a system called the \u003cstrong\u003eSalivary Excretion Classification System (SECS)\u003c\/strong\u003e, which sorts drugs into four classes:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eClass I\u003c\/strong\u003e: Low protein binding, high intestinal permeability — efficiently excreted into saliva\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eClass II\u003c\/strong\u003e: Low protein binding, low intestinal permeability — also efficiently excreted into saliva\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eClass III\u003c\/strong\u003e: High protein binding, high intestinal permeability — moderately secreted through passive diffusion, despite low free drug fractions\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eClass IV\u003c\/strong\u003e: High protein binding and low intestinal permeability — negligible salivary concentrations due to limited passive diffusion; these drugs are generally unsuitable for saliva-based TDM\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIn simple terms, drugs that aren't heavily bound to blood proteins and that can pass through membranes are good candidates for saliva testing. Drugs that are tightly bound to proteins and can't cross membranes easily are not.\u003c\/p\u003e\n\n\u003ch2 id=\"drugs\"\u003eRepresentative Research Cases\u003c\/h2\u003e\n\u003cp\u003eThe review highlighted six representative drugs studied in detail. Here's what the researchers found for each.\u003c\/p\u003e\n\n\u003ch3\u003eAmikacin: A Lifesaving Antibiotic for Newborns\u003c\/h3\u003e\n\u003cp\u003eAmikacin is an intravenous antibiotic often used to treat serious infections in premature and full-term newborns. In a study by Samb and colleagues, \u003cstrong\u003e23 preterm and term neonates\u003c\/strong\u003e were studied, and researchers built a mathematical model that connected a simulated saliva compartment to a previously validated two-compartment plasma model.\u003c\/p\u003e\n\u003cp\u003eUsing just \u003cstrong\u003e1 to 5 simulated salivary concentrations\u003c\/strong\u003e, researchers performed dose adjustments. The results were striking: \u003cstrong\u003e77.6% to 79.2% of simulated patients achieved the target plasma concentrations\u003c\/strong\u003e (peak levels between 24-35 mg\/L and trough levels below 5 mg\/L). This outperformed the fixed-dose approach, where only \u003cstrong\u003e73.1%\u003c\/strong\u003e of patients reached their targets.\u003c\/p\u003e\n\u003cp\u003eThe researchers noted that saliva-based TDM could be especially valuable for \u003cstrong\u003epreterm newborns experiencing delayed-onset sepsis\u003c\/strong\u003e — a life-threatening condition where every blood draw carries added risk.\u003c\/p\u003e\n\n\u003ch3\u003eVoriconazole: An Antifungal Medication\u003c\/h3\u003e\n\u003cp\u003eVoriconazole treats serious fungal infections. Kim and colleagues used a one-compartment model with first-order absorption and elimination to characterize the drug's behavior. They introduced a \u003cstrong\u003eproportionality factor of 0.501\u003c\/strong\u003e to correlate salivary voriconazole levels with the stable plasma compartment.\u003c\/p\u003e\n\u003cp\u003eThis adjustment improved the model's accuracy compared to using a separate salivary compartment in isolation. The model's predictive performance was validated through visual predictive checks and simulations, offering a promising pathway for saliva-based voriconazole dosing.\u003c\/p\u003e\n\n\u003ch3\u003eGentamicin: Another Key Neonatal Antibiotic\u003c\/h3\u003e\n\u003cp\u003eA study by Samb and colleagues involved \u003cstrong\u003e54 neonates treated with gentamicin\u003c\/strong\u003e. The research team used a non-linear mixed effects model (NONMEM) to build a population pharmacokinetic model, integrating salivary gentamicin concentrations into a previously published two-compartment model.\u003c\/p\u003e\n\u003cp\u003eThe simulations revealed that \u003cstrong\u003eTDM using four saliva samples achieved target attainment rates of 81%\u003c\/strong\u003e. Interestingly, this actually outperformed plasma-based approaches in some comparisons (94% with two plasma samples; 87% with one sample). The model provided actionable insights to optimize gentamicin dosing in newborns, confirming that saliva-based TDM is a \u003cstrong\u003eclinically viable strategy\u003c\/strong\u003e for this drug.\u003c\/p\u003e\n\n\u003ch3\u003eClonazepam: A Seizure Medication\u003c\/h3\u003e\n\u003cp\u003eKruizinga and colleagues studied \u003cstrong\u003e20 healthy subjects\u003c\/strong\u003e to develop a population pharmacokinetic model for clonazepam, a medication used for seizures and panic disorders. They discovered an important practical issue: when patients take an oral solution, the liquid can contaminate saliva samples during the \u003cstrong\u003efirst four hours after dosing\u003c\/strong\u003e, causing a non-linear relationship between saliva and plasma concentrations.\u003c\/p\u003e\n\u003cp\u003eThe researchers introduced a mathematical adjustment to account for this contamination. Using Bayesian maximum a posteriori optimization, they found that when only \u003cstrong\u003eone saliva sample\u003c\/strong\u003e was collected, the limits of agreement (LOA) between true and predicted plasma concentrations ranged from \u003cstrong\u003e−28% to +36%\u003c\/strong\u003e. When more saliva samples were collected, these limits improved to \u003cstrong\u003e−18% to +17%\u003c\/strong\u003e — a much tighter and more clinically acceptable range.\u003c\/p\u003e\n\u003cp\u003eThe researchers recommend that patients \u003cstrong\u003ethoroughly rinse their mouths\u003c\/strong\u003e after taking oral solutions to avoid this contamination problem. They also noted that regular tablets might avoid this issue, but the oral solution was studied because the target population includes children.\u003c\/p\u003e\n\n\u003ch3\u003eBusulfan: A Chemotherapy Drug Requiring Precise Dosing\u003c\/h3\u003e\n\u003cp\u003eBusulfan is a powerful chemotherapy drug used before bone marrow transplantation, where precise dosing is critical — too little means the transplant may fail; too much means severe toxicity. Xu and colleagues studied \u003cstrong\u003e66 patients with hematological malignancies\u003c\/strong\u003e (blood cancers).\u003c\/p\u003e\n\u003cp\u003eTheir population pharmacokinetic model used a one-compartment model with constant-rate infusion. They compared two approaches for incorporating salivary concentrations and determined that a \u003cstrong\u003eproportionality factor within the plasma compartment was superior\u003c\/strong\u003e to creating a separate saliva compartment.\u003c\/p\u003e\n\u003cp\u003eThe Monte Carlo simulation results were impressive: a root mean square percentage error (a measure of prediction accuracy) as low as \u003cstrong\u003e13.74%\u003c\/strong\u003e, with 95% limits of agreement ranging from \u003cstrong\u003e−23.40% to +31.92%\u003c\/strong\u003e using just a single trough saliva sample. This means the model is clinically applicable for individualizing busulfan dosing based on salivary drug concentration.\u003c\/p\u003e\n\n\u003ch3\u003ePrednisolone: A Steroid With a Surprising Finding\u003c\/h3\u003e\n\u003cp\u003ePrednisolone is an active steroid medication, and its inactive precursor is prednisone. Once taken, prednisone converts to prednisolone in the body. Nynke Teeninga and colleagues studied \u003cstrong\u003e19 healthy volunteers\u003c\/strong\u003e to understand this metabolic relationship.\u003c\/p\u003e\n\u003cp\u003eThe key finding was a \u003cstrong\u003estrong correlation (r = 0.931, P \u0026lt; .01)\u003c\/strong\u003e between salivary prednisolone and free serum prednisolone concentrations. In contrast, the correlation between salivary prednisone and serum prednisone was weak \u003cstrong\u003e(r = 0.318, P \u0026lt; .01)\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eThis is statistically highly significant — the P value of less than 0.01 means there is less than a 1% chance this finding occurred by random chance. The clinical takeaway: saliva-based monitoring of prednisolone is a reliable stand-in for systemic free drug levels, offering a non-invasive alternative for patients who need long-term steroid monitoring.\u003c\/p\u003e\n\n\u003ch2 id=\"factors\"\u003eFactors That Affect Saliva Drug Levels\u003c\/h2\u003e\n\u003cp\u003eThe review identified many factors that influence whether — and how much — a drug appears in saliva. This isn't a simple process, and these factors can affect accuracy.\u003c\/p\u003e\n\n\u003ch3\u003eDoes the Patient Produce Enough Saliva?\u003c\/h3\u003e\n\u003cp\u003eSaliva comes from three pairs of major glands: the \u003cstrong\u003eparotid, submandibular, and sublingual glands\u003c\/strong\u003e. Many things affect saliva production:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCircadian rhythm\u003c\/strong\u003e: Saliva flow peaks in the afternoon and varies throughout the day\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBody position\u003c\/strong\u003e: Flow increases when standing and decreases when lying down\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHydration\u003c\/strong\u003e: More water intake increases saliva; dehydration decreases it\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFood and drink\u003c\/strong\u003e: Acidic foods and carbonated beverages stimulate saliva production\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEmotions\u003c\/strong\u003e: Anxiety, nervousness, anger, and excitement may change saliva production, though studies are limited\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eMany common medications also reduce saliva, including:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003ePain relievers (analgesics) and appetite suppressants\u003c\/li\u003e\n  \u003cli\u003eAntirheumatic drugs and anticholinergics\u003c\/li\u003e\n  \u003cli\u003eAntidiarrheal and antiemetic medications\u003c\/li\u003e\n  \u003cli\u003eAntihistamines (allergy medications) and antihypertensives (blood pressure medications)\u003c\/li\u003e\n  \u003cli\u003eDiuretics (water pills) and medications for Parkinson's disease\u003c\/li\u003e\n  \u003cli\u003eAnti-anxiety medications, antidepressants, and antipsychotic medications\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCertain diseases also reduce saliva production, including \u003cstrong\u003econgenital dry mouth or dry mouth syndrome\u003c\/strong\u003e, chronic rheumatoid arthritis, graft-versus-host disease after bone marrow transplantation, systemic lupus erythematosus, alcoholic cirrhosis of the liver, cystic fibrosis, Addison's disease, Cushing's syndrome, primary aldosteronism, and radiation therapy for head and neck cancers. Age and gender can play a role too — salivary flow tends to be higher in men than women, though studies on age effects have produced conflicting results.\u003c\/p\u003e\n\n\u003ch3\u003eThe Saliva-to-Plasma (S\/P) Ratio\u003c\/h3\u003e\n\u003cp\u003eTo use saliva for TDM, there must be a predictable relationship between drug concentrations in saliva and those in plasma (blood). This relationship is called the \u003cstrong\u003esaliva\/plasma (S\/P) ratio\u003c\/strong\u003e, and it varies between drugs.\u003c\/p\u003e\n\u003cp\u003eSeveral factors affect the S\/P ratio:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMolecular weight\u003c\/strong\u003e: Large drug molecules have difficulty entering saliva, except in unusual situations like breaks in the oral mucosa\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLipid solubility\u003c\/strong\u003e: Drugs that dissolve well in fats are more likely to enter saliva through free diffusion — this is the main factor controlling drug movement from blood to saliva\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrug ionization (pKa)\u003c\/strong\u003e: Only non-ionized (uncharged) drug molecules can cross cell membranes. The drug's pKa and the pH of saliva both matter. For basic drugs, a higher pKa means more ionization and less entry into saliva; the opposite is true for acidic drugs\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003epH differences\u003c\/strong\u003e: Normal plasma pH is 7.35-7.45, while saliva pH ranges from 5.8 to 7.8. Because plasma is more basic than saliva, acidic drugs typically have S\/P ratios of ≤1, while basic drugs typically have S\/P ratios of ≥1\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eProtein binding\u003c\/strong\u003e: Drug molecules attached to plasma proteins can't pass through capillary walls, so drugs with high protein binding have difficulty entering saliva\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThere's also an important phenomenon related to \u003cstrong\u003earteriovenous differences\u003c\/strong\u003e. During drug absorption, the drug concentration in arterial blood is higher than in venous blood. During elimination, this can reverse. Salivary glands have abundant blood flow, so these fluctuations must be considered when comparing saliva concentrations with blood drawn from a vein in the arm.\u003c\/p\u003e\n\u003cp\u003eDifferent elimination kinetics in plasma versus saliva can also make the S\/P ratio unstable. Finally, when a drug's S\/P ratio shows high variability, saliva becomes a more difficult TDM matrix to use reliably.\u003c\/p\u003e\n\n\u003ch3\u003eAssay Sensitivity Is Essential\u003c\/h3\u003e\n\u003cp\u003eDrug concentrations in saliva are usually lower than those in plasma. This means \u003cstrong\u003ehighly sensitive laboratory tests are a prerequisite\u003c\/strong\u003e — the drug concentration must reach the lowest detection limit of the assay before TDM can be performed. If the test isn't sensitive enough, saliva TDM simply won't work reliably.\u003c\/p\u003e\n\n\u003ch2 id=\"implications\"\u003eWhat This Means for Patients\u003c\/h2\u003e\n\u003cp\u003eThis research could meaningfully change how certain medications are monitored. Here's what it means in practical terms:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLess pain for newborns\u003c\/strong\u003e: Premature and full-term infants often need antibiotics like amikacin and gentamicin. Saliva-based monitoring could significantly reduce the number of blood draws these fragile patients endure, lowering the risk of anemia and infection.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBetter care for needle-phobic patients\u003c\/strong\u003e: Children who fear needles, individuals with intellectual disabilities, and immunocompromised patients could all benefit from a painless monitoring option.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHome-based monitoring\u003c\/strong\u003e: Since family members can collect saliva samples without special training, patients could potentially have samples collected at home and mailed to a laboratory, reducing hospital visits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMore accurate measurement of active drug\u003c\/strong\u003e: Because saliva reflects free (unbound) drug concentrations rather than total drug (bound plus unbound), saliva TDM may actually provide a more accurate picture of the drug that's working in the body.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSmarter dosing with mathematical models\u003c\/strong\u003e: The population pharmacokinetic models described in this review can predict plasma drug levels from saliva measurements, enabling doctors to adjust doses with fewer data points.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"limitations\"\u003eStudy Limitations\u003c\/h2\u003e\n\u003cp\u003eIt's important to understand what this research doesn't prove.\u003c\/p\u003e\n\u003cp\u003eFirst, \u003cstrong\u003enot all drugs can be monitored through saliva\u003c\/strong\u003e. Thirteen of the 73 drugs studied (17.8%) were not suitable, and 7 more produced conflicting results. Drugs with high protein binding and low permeability (SECS Class IV) are generally unsuitable.\u003c\/p\u003e\n\u003cp\u003eSecond, \u003cstrong\u003epatient-specific factors complicate saliva testing\u003c\/strong\u003e. Saliva production varies with age, gender, medications, diseases, hydration status, time of day, body position, and even emotions. A patient with dry mouth from another medication may not produce enough saliva for testing.\u003c\/p\u003e\n\u003cp\u003eThird, \u003cstrong\u003ethe S\/P ratio isn't always constant\u003c\/strong\u003e. For drugs like clonazepam, the oral solution itself contaminated saliva samples. Arteriovenous differences, nonlinear elimination kinetics, and concentration-dependent protein binding can all make saliva levels unpredictable.\u003c\/p\u003e\n\u003cp\u003eFourth, \u003cstrong\u003esaliva-based PopPK modeling is still in its infancy\u003c\/strong\u003e. The review notes that population pharmacokinetic modeling based on saliva TDM for precise drug delivery has only been initially attempted for a few drugs, and the application \u003cstrong\u003ehas yet to be verified in large clinical studies\u003c\/strong\u003e. Most current saliva TDM research has been conducted abroad, with limited research in China.\u003c\/p\u003e\n\u003cp\u003eFinally, \u003cstrong\u003esensitivity of laboratory assays\u003c\/strong\u003e is a practical barrier. Saliva drug concentrations are often lower than plasma concentrations, requiring more sensitive — and potentially more expensive — laboratory equipment.\u003c\/p\u003e\n\n\u003ch2 id=\"recommendations\"\u003eRecommendations for Patients and Researchers\u003c\/h2\u003e\n\u003cp\u003eFor patients currently undergoing therapeutic drug monitoring, it's worth asking your physician or pharmacist whether saliva-based testing might be an option for your specific medication. While saliva TDM isn't yet widely available in clinical practice, the evidence supporting it for drugs like amikacin, gentamicin, voriconazole, busulfan, and prednisolone is substantial.\u003c\/p\u003e\n\u003cp\u003eFor patients participating in saliva TDM studies or future clinical use, the research suggests these practical tips:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRinse your mouth thoroughly\u003c\/strong\u003e after taking oral medications, especially liquid formulations, to avoid contamination of saliva samples\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBe consistent with collection timing\u003c\/strong\u003e, since salivary flow varies by time of day, with peaks typically in the afternoon\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStay well-hydrated\u003c\/strong\u003e, as dehydration reduces saliva flow and could affect sample adequacy\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDisclose all medications you take\u003c\/strong\u003e, including over-the-counter drugs, since many common medications reduce saliva production\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFollow instructions about body position\u003c\/strong\u003e, since lying down versus standing can alter saliva flow rates\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eFor researchers, the authors recommend continued development of saliva-based PopPK models for additional drugs, standardized methods for correlating saliva and plasma concentrations, and large-scale clinical trials to verify that saliva-guided dosing achieves outcomes comparable to traditional blood-based TDM.\u003c\/p\u003e\n\n\u003c!-- ddn:faq:start --\u003e\n\u003ch2 id=\"ddn-faq\"\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003ch3\u003eWhat is therapeutic drug monitoring and why is it done?\u003c\/h3\u003e\n\u003cp\u003eTherapeutic drug monitoring measures drug levels in your body to keep them in a safe, effective range. Levels that are too low may not treat your condition; levels that are too high can cause dangerous side effects. Traditionally it uses blood samples, but saliva may offer a painless alternative for some medications.\u003c\/p\u003e\n\u003ch3\u003eHow does saliva drug testing compare to blood testing for accuracy?\u003c\/h3\u003e\n\u003cp\u003eSaliva reflects the free, active drug in your body, while blood measures total drug. Mathematical models can predict blood levels from saliva samples. For example, one study achieved target gentamicin levels in 81% of newborns using four saliva samples. Accuracy depends on the drug and collection method.\u003c\/p\u003e\n\u003ch3\u003eWhat factors can affect saliva drug levels and test accuracy?\u003c\/h3\u003e\n\u003cp\u003eSaliva production varies with time of day, body position, hydration, food, emotions, age, and gender. Many medications and diseases reduce saliva flow. Drug properties like protein binding and pH also affect saliva levels. Rinsing your mouth and staying hydrated can improve accuracy.\u003c\/p\u003e\n\u003ch3\u003eIs saliva testing painful and can I do it at home?\u003c\/h3\u003e\n\u003cp\u003eYes, saliva collection is painless and requires no special training, so samples can be collected at home and mailed to a lab. This is especially helpful for newborns, needle-phobic patients, and those who need frequent monitoring. However, not all drugs can be measured this way yet.\u003c\/p\u003e\n\u003ch3\u003eWhat should I do if I'm having saliva drug level testing?\u003c\/h3\u003e\n\u003cp\u003eRinse your mouth thoroughly after taking oral medications, especially liquids, to avoid contaminating the sample. Collect samples at the same time each day, stay well-hydrated, tell your doctor about all medications you take, and follow instructions about body position, since lying down can affect saliva flow.\u003c\/p\u003e\n\u003ch3\u003eAre there risks or limitations to saliva drug monitoring?\u003c\/h3\u003e\n\u003cp\u003eSaliva testing is not suitable for all drugs, especially those that are highly protein-bound. Laboratory assays must be sensitive enough to detect low saliva drug concentrations. Patient factors like dry mouth can affect sample adequacy. Large clinical studies are still needed before widespread use.\u003c\/p\u003e\n\u003ch3\u003eWhen should I seek a second opinion about using saliva testing instead of blood draws for monitoring my medication?\u003c\/h3\u003e\n\u003cp\u003eSaliva testing is a painless option for monitoring many medications, but it doesn't work for every drug. Among 73 drugs studied, 53 (73.6%) were reliably measurable in saliva, while 13 were not and 7 gave conflicting results. Drugs that are highly protein-bound and poorly permeable generally cannot be monitored this way. If your medication is being monitored with frequent blood draws, a second opinion could clarify whether saliva-based monitoring is a viable, evidence-backed alternative for your specific drug. Diagnostic Detectives Network provides independent expert second opinions on medication monitoring options.\u003c\/p\u003e\n\u003c!-- ddn:faq:end --\u003e\n\n\u003ch2 id=\"source\"\u003eSource Information\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eOriginal article title:\u003c\/strong\u003e Saliva as a TDM Matrix and Its Application in the Model-Informed Precision Dosing.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthors:\u003c\/strong\u003e Xu B, Wen Y, Lu J, Liu M, Luo X, Huang W, Xie H, Cheng Y, Qiu H, Wu X.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eJournal:\u003c\/strong\u003e The Journal of Clinical Pharmacology, 2025, Volume 65, Issue 12, Pages 1650–1660\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublication details:\u003c\/strong\u003e Published by Wiley Periodicals LLC on behalf of the American College of Clinical Pharmacology. DOI: 10.1002\/jcph.70083\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCorresponding author:\u003c\/strong\u003e Xuemei Wu, PhD, Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China\u003c\/p\u003e\n\u003cp\u003eThis patient-friendly article is based on peer-reviewed research. The original study was submitted on February 24, 2025, and accepted on June 29, 2025.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eNote: This article is provided for educational purposes only and is not a substitute for professional medical advice. Always discuss medication monitoring options with your healthcare provider.\u003c\/em\u003e\u003c\/p\u003e","brand":"DiagnosticDetectives.Com","offers":[{"title":"Default Title","offer_id":47494454214812,"sku":null,"price":0.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/diagnosticdetectives.com\/products\/saliva-testing-a-painless-alternative-for-monitoring-medications-and-precision-dosing","provider":"DiagnosticDetectives.Com","version":"1.0","type":"link"}